共 67 条
[1]
Avery R(1996)Natural history of subretinal subfoveal haemorrhage in age-related macular degeneration Retina 16 183-189
[2]
Fekrat S(2004)Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13 Ophthalmology 111 1993-2006
[3]
Hawkins B(2004)Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration Ophthalmology 111 1201-1208
[4]
Bressler N(2007)Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection Retina 27 329-334
[5]
Bressler NM(2006)Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator Br J Ophthalmol 90 429-431
[6]
Bressler SB(2009)Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration Eye 23 1404-1410
[7]
Childs AL(2007)Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage Am J Ophthalmol 144 886-892
[8]
Haller JA(2008)Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study Acta Ophthalmol 86 490-494
[9]
Hawkins BS(2006)Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419-1431
[10]
Lewis H(2007)An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 566-583